Cresset Asset Management »

Sensei Biotherapeutics shares owned by Cresset Asset Management

Quarter-by-quarter ownership of Sensei Biotherapeutics (SNSE) shares owned by Cresset Asset Management from 13F filings

Historical chart of Cresset Asset Management investment in Sensei Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Sensei Biotherapeutics held by Cresset Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sensei Biotherapeutics by Cresset Asset Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $21k 20k 1.05

More positions owned by Cresset Asset Management

Arista Networks Put Option (ANET)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Core S&p Scp Etf (IJR)
Ishares Tr S&p 100 Etf (OEF)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Apple (AAPL)
Microsoft Corporation (MSFT)
Meta Platforms Cl A Put Option (META)
Ishares Tr Core Msci Eafe (IEFA)
Vanguard Intl Equity Index F Allwrld Ex Us (VEU)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
NVIDIA Corporation Put Option (NVDA)
Vanguard Index Fds Total Stk Mkt (VTI)

View all positions for Cresset Asset Management

Top funds holding Sensei Biotherapeutics

Newtyn Management
Vanguard Group
Renaissance Technologies
Geode Capital Management
Bridgeway Capital Management
Bank of America Corporation
BlackRock
Millennium Management
Northern Trust
State Street Corporation
Citadel Advisors
Cresset Asset Management
Two Sigma Advisers
Leo Wealth
Raymond James & Associates

View all funds holding Sensei Biotherapeutics